Herceptin Approved In Two New Regimens
This article was originally published in The Pink Sheet Daily
Executive Summary
Carboplatin substitutes for anthracyclines to reduce cardiac risk.
You may also be interested in...
Herceptin Approved For Every-Three-Week Dosing In Breast Cancer
Trastuzumab is cleared for adjuvant treatment in HER2-positive node-positive and node-negative breast cancer as a single agent or combined with hormonal therapy.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
Alzheimer’s, BRAIN Initiative Highlighted In $30 Billion NIH Budget Proposal
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.